<-- -->

Lipid Luminations

A New Therapeutic Option for Patients With Statin-Associated

Dyslipidemia in the United States–Where Do We Stand?

Treatment Induced HDL-C Change Is Not Associated with Cardiovascular Benefit in Metaregression Analysis

Rosuvastatin Prevents Vascular Events in Men and Women with Elevated C-Reactive Protein but Without Elevated Low-Density Lipoprotein Cholesterol

A 2-year Head-to-Head Comparison of the Low Fat, Low Carbohydrate and Mediterranean Diets

Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib

What to make of the Enhance Study?

Safety of Statins - A Meta-Analysis of the Incidence of Raised Liver Enzymes, Rhabdomyolysis and Cancer in Clinical Trials with statins

Safety of Statins – A Meta-Analysis of the Incidence of Raised Liver Enzymes, Rhabdomyolysis and Cancer in Clinical Trials with Statins

Whither HDL-C Raising?

CAD and high HDL

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

Should maximum dose statin therapy be routinely used to prevent coronary heart disease and stroke in secondary prevention?

New Approaches to the Management of Obesity and the Metabolic Syndrome?

A Tale of Two PPAR Agonists

Taking a Pill to Boost HDL Function in Mice

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

C-reactive protein levels and outcomes after statin therapy

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the CARDS Study

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5,963 people with diabetes: a randomized placebo-controlled trial

Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice

Do statins have important clinical effects beyond lowering of LDL-cholesterol

Statins and Risk of Polyneuropathy

Platelet Receptor Inhibition in Ischemic Syndrome Management

Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis